The TGF-β pathway has a dual role in cancer, because it prevents cell proliferation in early stages and in advanced stages stimulates proliferation, epithelial-to-mesenchymal transition (EMT) and evasion of immune surveillance, and attenuates apoptosis [128]. Here, TGFB1 is linked to cancer.